Results for tag: "Avastin Biosimilars"

Avastin Biosimilars are biotechnological products that are similar to the original Avastin drug, a cancer treatment developed by Genentech. Avastin Biosimilars are developed by other companies and are approved by the FDA as interchangeable with the original drug. These biosimilars are designed to provide the same therapeutic benefits as the original drug, but at a lower cost. Avastin Biosimilars are used to treat a variety of cancers, including colorectal, lung, and breast cancer. They are also used to treat certain eye conditions, such as age-related macular degeneration. Avastin Biosimilars are becoming increasingly popular due to their cost-effectiveness and safety. Some companies in the Avastin Biosimilars market include Amgen, Pfizer, Sandoz, and Mylan. Show Less Read more